Journal
DRUG DISCOVERY TODAY
Volume 25, Issue 8, Pages 1513-1520Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2020.06.006
Keywords
-
Categories
Funding
- Council for At-Risk Academics (CARA)
- Egyptian Culture Centre
- Educational Bureau in London
Ask authors/readers for more resources
Recently, remarkable efforts have focused on research towards enhancing and delivering efficacious and advanced therapeutic agents. Even though this involves significant challenges, innovative techniques and materials have been explored to overcome these. The advantageous properties of mesoporous silica nanoparticles (MSNs), such as unique morphologies and geometries, makes then favorable for use for various drug delivery targeting purposes, particularly in cancer therapy. As we discuss here, MSNs have been utilized over the past few decades to improve the efficiency of anticancer drugs by enhancing their solubility to render them suitable for application, reducing adverse effects, and improving their anticancer cytotoxic efficiency.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available